All In Biotech

Drug Trial Radar · NCT04278417

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

A 96-week, Two-arm, Randomized, Single-masked, Multi-center, Phase III Study Assessing the Efficacy and Safety of Brolucizumab 6 mg Compared to Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

Last checked: Nov 20, 2026Latest source record: Oct 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 689 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

689

Actual

Start

Nov 19, 2020

Primary completion

Oct 30, 2023

Study completion Aug 19, 2024

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Feb 20, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to evaluate the efficacy and safety of brolucizumab compared to panretinal photocoagulation laser (PRP) in patients with proliferative diabetic retinopathy (PDR). This evaluation will provide information that brolucizumab is non-inferior to PRP with respect to the change in best corrected visual acuity at Week 54.

Conditions

  • Proliferative Diabetic Retinopathy

Interventions

  • Brolucizumab 6 mgBiological

    3 x q6w loading injections, followed by q12w maintenance through Week 90

  • Panretinal photocoagulation laserProcedure

    initial treatment in 1-4 sessions up to Week 12, followed with additional PRP treatment as needed

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Best-corrected Visual Acuity (BCVA) at Week 54 for the Study EyeTime frame: Baseline, Week 54

Locations

120 sites in 16 countries. Site status is shown where the registry gives one.

  • Retina Associates SW

    Tucson, Arizona

  • Retina- Vitreous Assoc Medical Group

    Beverly Hills, California

  • Retina Consultants of Orange County

    Fullerton, California

  • Salehi Retina Institute

    Huntington Beach, California

  • Retina Consultants of Southern California

    Redlands, California

  • Premiere Practice Management LLC

    Torrance, California

  • Lundquist Inst BioMed at Harbor

    Torrance, California

  • Miramar Eye Specialists

    Ventura, California

  • Advanced Research LLC

    Deerfield Beach, Florida

  • Rand Eye Institute

    Deerfield Beach, Florida

  • Pinnacle Research Institute

    Fort Lauderdale, Florida

  • National Ophthalmic Research Institute

    Fort Myers, Florida

  • Florida Retina Institute

    Jacksonville, Florida

  • Blue Oc Clin Res at Palm Bch Eye Ct

    Lakeland, Florida

  • MedEye Associates

    Miami, Florida

  • Florida Retina Institute

    Orlando, Florida

  • Eye Center of North Florida

    Panama City, Florida

  • Fort Lauderdale Eye Institute

    Plantation, Florida

  • Retina Associates

    Elmhurst, Illinois

  • Midwest Eye Institute

    Indianapolis, Indiana

  • John-Kenyon American Eye Institute PC

    New Albany, Indiana

  • Retina Associates PA

    Lenexa, Kansas

  • Cumberland Valley Retina Consultants

    Hagerstown, Maryland

  • University of Mississippi Med Ctr

    Jackson, Mississippi

  • Retina Associates Of Cleveland

    Cleveland, Ohio

  • Dean McGee Eye Institute

    Oklahoma City, Oklahoma

  • Cascade Medical Research Institute

    Springfield, Oregon

  • Erie Retinal Surgery

    Erie, Pennsylvania

  • Charleston Neuroscience Institute

    Ladson, South Carolina

  • Southeastern Retina Associates P C

    Knoxville, Tennessee

  • Austin Retina Associates

    Austin, Texas

  • Texan Eye P A

    Austin, Texas

  • Retina And Vitreous Of Texas

    Bellaire, Texas

  • Retina Consultants TX Rsrch Ctr

    Bellaire, Texas

  • Texas Retina Associates

    Fort Worth, Texas

  • Valley Retina Institute PA

    Harlingen, Texas

  • Retina Consultants of Houston PA

    Houston, Texas

  • Medical Center Opthamology Assoc

    San Antonio, Texas

  • Retina Associates Of South Texas PA

    San Antonio, Texas

  • Virginia Eye Consultants

    Norfolk, Virginia

Showing 40 of 120 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.